RevBio, Inc.
Transforming Bone Repair
Lowell, United States
32 employees
Grant
Total: $35.09M
Biotechnology, Health Care +1
General Information
Lowell, United States
BounceWatch is an independent company data service, not affiliated with RevBio, Inc.. To contact RevBio, Inc., visit revbio.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
Discover More
United States Market
Biotechnology
About RevBio, Inc.
Taxonomy: Medicine, Biomaterials, Medical Device, Dental, Veterinary, Biomimetics, Bone Graft, Orthopaedics, Prosthodontics, Oral Surgery, Neurosurgery, Innovation, Bone Repair, Biocompatible Adhesive, Trauma
Funding Rounds & Investors (15)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Grant | $2.00M | 1 |
National Institutes of Health
|
25 Oct 2023 |
| Grant | $3.40M | 1 |
National Institute on Aging
|
06 Oct 2023 |
| Grant | $2.00M | 1 |
National Institute of Dental and Craniofacial Research (NIDCR)
|
07 Jun 2023 |
| Corporate Round | Undisclosed | 1 |
|
14 Feb 2023 |
| Grant | Undisclosed | 1 |
National Institute on Aging
|
20 Sep 2022 |
| Non Equity Assistance | Undisclosed | 1 |
|
07 Jun 2022 |
| Seed Round | $9.01M | - |
|
11 Jun 2021 |
| Grant | $1.80M | 1 |
|
02 Jun 2020 |
| Grant | $2.50M | 1 |
National Institute of Neurological Disorders and Stroke
|
05 May 2020 |
| Seed Round | $9.50M | - |
|
21 Dec 2019 |
RevBio, Inc. Alternatives & Competitors
View All Alternatives
Global Leader in Synthetic & Resorbable Biomaterials
MIS COREX™ is designed to capture and preserve cancellous autograft with one simple mechanism.
Founded in 2005, Graftys develops, manufactures and markets patented synthetic bone biomaterials, in...
FAQ About RevBio, Inc.
Source: BounceWatch company record for RevBio, Inc., https://bouncewatch.com/company/revbio-inc, updated 30 December 2024. When citing, please name BounceWatch and link this page.
